Montesinos, P., Labrador, J., Lloret-Madrid, P. (2026). Reply to: Quizartinib for Newly Diagnosed
                    <i>FLT3</i>
                    -Internal Tandem Duplication–Negative AML. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-00338